Elevance Health (ELV) Payables (2009 - 2026)

Elevance Health (ELV) has reported Payables for 18 consecutive years, with $6.6 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables fell 13.17% year-over-year to $6.6 billion in Q2 2026; TTM through Jun 2026 was $6.6 billion, a 13.17% decrease from a year earlier, with the FY2025 full-year figure at $7.5 billion, up 2.47% from the prior year.
• Payables was $6.6 billion for Q2 2026 at Elevance Health, down from $6.9 billion in the prior quarter.
• Over five years, Payables peaked at $7.6 billion in Q2 2025 and troughed at $5.1 billion in Q1 2023.
• A 5-year average of $6.4 billion and a median of $6.4 billion in 2024 frame the typical range for Payables.
• Across the five-year window, Payables decreased 14.78% in 2022 and jumped 40.77% in 2024, its largest moves.
• Over 5 years, Payables stood at $5.9 billion in 2022, then advanced by 21.51% to $7.1 billion in 2023, then grew by 2.2% to $7.3 billion in 2024, then rose by 2.47% to $7.5 billion in 2025, then dropped by 11.24% to $6.6 billion in 2026.
• The last three Payables figures came in at $6.6 billion (Q2 2026), $6.9 billion (Q1 2026), and $7.5 billion (Q4 2025), per Business Quant data.